Note: This webinar took place on the 04-May-2017. You can find a video recording and the presentations used during the webinar below.
A very important result from the EUPATI project was the development, broad consultation and final release of guidances on the best approach to interaction of patients with pharmaceutical industry-led medicines R&D, regulatory authorities, ethics committees and HTA agencies. This webinar focuses on the Guidance on Patient Involvement in Industry-led R&D.
- Kay Warner, GSK
- Wolf See, EMTRAIN
- David Haerry, EATG
- Ingrid Klingmann, EFGCP